Traductor

03 March 2014

Mylan Fourth Quarter 2013 Adjusted Diluted EPS Increases 20% to $0.78 and Full Year Adjusted Diluted EPS Increases 12% to $2.89

Mylan Inc. (Nasdaq: MYL) today announced its financial results for the three months and year ended December 31, 2013.
Financial Highlights
  • Adjusted diluted EPS of $0.78 for the three months ended December 31, 2013 compared to $0.65for the same prior year period, an increase of 20%
  • Total revenues of $1.81 billion for the three months ended December 31, 2013 compared to $1.72 billion for the same prior year period, an increase of 5%
  • On a GAAP basis, diluted EPS of $0.45 for the three months ended December 31, 2013 compared to $0.39 for the same prior year period, an increase of 15%
  • Adjusted diluted EPS of $2.89 for the year ended December 31, 2013 compared to $2.59 for the same prior year period, an increase of 12%
  • Total revenues of $6.91 billion for the year ended December 31, 2013 compared to $6.80 billion for the same prior year period, an increase of 2%, despite 2013 new product revenues being 69% lower than 2012
  • On a GAAP basis, diluted EPS of $1.58 for the year ended December 31, 2013 compared to $1.52for the same prior year period, an increase of 4%
  • Adjusted operating cash flow of $1.20 billion for the year ended December 31, 2013. On a GAAP basis, cash flow from operating activities of $1.11 billion for the year ended December 31, 2013

No comments:

Post a Comment

CONTACTO · Aviso Legal · Política de Privacidad · Política de Cookies

Copyright © Noticia de Salud